tiprankstipranks
Trending News
More News >
Veracyte (VCYT)
NASDAQ:VCYT

Compare Veracyte (VCYT) vs. Competitors

Compare
563 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Veracyte
$42.45
$3.36B
111.80
3.39%
6 Buy
1 Hold
1 Sell
Moderate Buy
Travere Therapeutics
$29.11
$2.59B
-26.67
69.48%
11 Buy
2 Hold
0 Sell
Strong Buy
Celcuity
$104.21
$5.30B
-31.18
987.18%
8 Buy
1 Hold
0 Sell
Strong Buy
Immunovant
$26.18
$5.20B
19.54%
7 Buy
2 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$26.05
$3.27B
-75.40
101.28%
7 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$75.44
$2.91B
-14.39
33.29%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VCYT
Veracyte
42.45
1.35
3.28%
TVTX
Travere Therapeutics
28.93
10.46
56.63%
CELC
Celcuity
114.48
103.23
917.60%
IMVT
Immunovant
27.35
3.55
14.92%
ARQT
Arcutis Biotherapeutics
26.73
12.98
94.40%
IRON
Disc Medicine
77.08
17.13
28.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts